37 results
Thumbnail

D1.216 - From Acetaminophen to sauerkraut

Thumbnail

D1.217 - Rapid drug desensitization in children: case report

Thumbnail

D1.219 - Impact of a Penicillin Allergy Delabeling Program on Antibiotic Selection and Perioperative Outcomes: A Prospective Comparative Cohort Study

Thumbnail

D1.222 - Comparative analysis and evaluation of clinical and stewardship implications of parent reported antibiotic allergy labels within paediatric care

Thumbnail

D1.223 - Evaluation of Immediate-Type Allergic Reactions to Amide Group Local Anesthetics In Children: A Single-Center

Thumbnail

D1.224 - Clinical performance of IgE Quaternary Ammoniums, Atracurium, Rocuronium and Suxamethonium for the diagnosis of an allergy to curares

Thumbnail

D1.225 - Direct single dose mass delabelling of antibiotic allergy in paediatrics

Thumbnail

D1.226 - Increased incidence of suspected clindamycin hypersensitivity reactions in pediatric patients due to its expanded use in clinical practice

Thumbnail

D1.227 - Risk stratification of drug allergy in children with immediate or delayed urticaria during antibiotic treatment

Thumbnail

D1.228 - Patch testing and HLA genotyping as diagnostic tools for DRESS related to concomitant multidrug exposure

Thumbnail

D1.229 - Limited interest of suxamethonium, rocuronium and atracurium specific IgE reagents for the diagnosis of NMBA allergy sensitization

Thumbnail

D1.230 - Acute Localized Exanthemathous pustulosis induced by Pertuzumab and Trastuzumab with positive Lymphocyte Transformation test

Thumbnail

D1.231 - When Antihistamines Paradoxically Worsen Chronic Spontaneous Urticaria: Trust Your Patient

Thumbnail

D2.351 - Relapse Rate and Risk Factors After Omalizumab Treatment in Adolescents with Chronic Spontaneous Urticaria

Thumbnail

D2.352 - Assessing Risk Factors for Relapse Following Omalizumab Discontinuation in Chronic Urticaria

Thumbnail

D2.353 - A Single Dose of Briquilimab, An Anti-Human CD117 (c-Kit) Antibody, Protects Against Relapse of Epicutaneous Allergen-Induced Dermatitis in Mice Expressing Chimeric Human/Mouse CD117

Thumbnail

D2.354 - Questionnaire survey of new treatments for atopic dermatitis

Thumbnail

D2.355 - Concurrent use of dupilumab and omalizumab in severe atopic dermatitis and severe chronic urticaria

Thumbnail

D2.356 - Real-life effectiveness of omalizumab and its impact on quality of life in patients with chronic spontaneous urticaria

Thumbnail

D2.357 - Characterizing chronic histaminergic angioedema and chronic urticaria with angioedema, a multicenter Italian experience